De Quervain's. Spontaneous rupture of synovium and tendon
Conditions
Interventions
Intervention 1: Intervention group: In this group of patients 1 CC autologous blood of the patient will be transfused at the site of affected tendon. Intervention 2: Control group: In this group of pa
Treatment - Other
Intervention group: In this group of patients 1 CC autologous blood of the patient will be transfused at the site of affected tendon.
Control group: In this group of patients placebo (normal saline) will be injected instead of autologous blood transfusion.
Sponsors
Vice Chancellor for research of Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Diagnosis of De Quervain's disease; age of 18 to 60 years; no history of rheumatic disorder such as rheumatoid arthritis; no history of depression and other mental disorders; no history of previous intervention for the treatment of De Quervain's disease. Exclusion criteria: loss of follow-up.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before the start of the intervention and after the end of the intervention. Method of measurement: visual analog scale.;Disability. Timepoint: Before the start of the intervention and after the end of the intervention. Method of measurement: Disabilities of the Arm, Shoulder and Hand (DASH) score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarid Najd Mazhar
Shafa Orthopedic Hospital
Outcome results
None listed